Our Process

Using gene expression data from patient samples, we apply our proprietary algorithm to classify patients by their unique molecular signatures. This process assigns each patient to a specific molecular subtype. From this stratification, we can identify likely responders for Clinical Trial Enrollment, as well as retroactively evaluate treatment response in each patient subtype.

Heterogenous Systemic Autoimmune Disorders

Sad Infographic

Get in Touch

If you are interested in ImmuType services and would like additional information.

Engage ImmuType